Eichhorn H J, Hüttner J, Dallüge K H, Welker K
Int J Radiat Oncol Biol Phys. 1983 Oct;9(10):1459-65. doi: 10.1016/0360-3016(83)90318-8.
Forty-two patients with histologically confirmed inoperable small (oat) cell lung cancer were treated with local tumor irradiation (approximately 4,000 cGy) combined with "one-time" irradiation of the upper and lower half of the body. Twenty-five patients (Group I) received the irradiation in lateral position first to the upper half-body, and six weeks later to the lower half-body, the midplane dose averaging 880 cGy (not corrected for lung tissue). In 17 patients, lethal pneumonitis occurred. The mean time of survival was 8.2 months for 22 patients having the disease limited to one thorax-side and 4.0 months for three patients having distant metastases, stated by conventional clinical and X ray investigations. Seventeen patients (Group II) received the two half-body irradiation treatments through anterior-posterior fields. The average dose had been reduced to 800 cGy (uncorrected) and was given on one day in two fractions (600 and 200 cGy, separated by an interval of 5 hours). Furthermore, the forearms and the lower legs had been left outside the fields. Only one patient showed pneumonitis. The mean time of survival was 14.3 months for 12 patients having the disease limited to one thorax-side and 6.6 months for five patients having distant metastases. In both groups, serious reactions of the bone marrow were not observed. In Group II, leucocytes and lymphocytes had reached their original values three months after the end of irradiation. For all 42 patients, X ray films showed complete regression of the primary tumor. In 12 out of 35 autopsy specimens, the primary tumor could not be detected histologically, but only five of these were free of metastases. Presently, additional irradiation of the two halves of the body with lower and fractionated doses are being tested in order to achieve the further reduction of tumor cell numbers.
42例经组织学确诊为无法手术的小(燕麦)细胞肺癌患者接受了局部肿瘤照射(约4000厘戈瑞),并结合对身体上、下半部的“一次性”照射。25例患者(第一组)先侧卧照射上半身,六周后照射下半身,中平面剂量平均为880厘戈瑞(未对肺组织进行校正)。17例患者发生了致死性肺炎。根据传统临床和X线检查,22例病变局限于一侧胸腔的患者平均生存时间为8.2个月,3例有远处转移的患者平均生存时间为4.0个月。17例患者(第二组)通过前后野接受了两次半身照射治疗。平均剂量已降至800厘戈瑞(未校正),分两次在一天内给予(600厘戈瑞和200厘戈瑞,间隔5小时)。此外,前臂和小腿未包括在照射野内。仅1例患者出现肺炎。12例病变局限于一侧胸腔的患者平均生存时间为14.3个月,5例有远处转移的患者平均生存时间为6.6个月。两组均未观察到严重的骨髓反应。在第二组中,白细胞和淋巴细胞在照射结束三个月后恢复到初始值。对所有42例患者进行的X线片检查显示原发肿瘤完全消退。在35份尸检标本中的12份中,组织学上未检测到原发肿瘤,但其中只有5份没有转移。目前,正在测试对身体两半部分进行更低剂量的分次照射,以进一步减少肿瘤细胞数量。